Skip to main content
 

Administration Preserves Patient Access to Certain Medications

Tuesday, March 11, 2014

On March 6, 2014 the Cancer Policy Institute at the Cancer Support Community (CSC) submitted a letter to the Centers for Medicare & Medicaid Services (CMS) raising concerns about how a proposed change in policy could hinder cancer patients’ access to certain types of medication.

Announcing Cancer Insurance Checklist: Guía de Cobertura Médica para Personas con Cáncer

Wednesday, February 5, 2014

The Spanish language version of the successful resource, the Cancer Insurance Checklist, is now available. This easy-to-use guide is available to assist people with cancer, a history of cancer or at risk for cancer choose a health insurance plan.

CSC’s Cancer Policy Institute supports FDA Access to User Fees

Friday, September 20, 2013

On September 10, 2013 the Cancer Support Community’s Cancer Policy Institute sent a letter of thanks and support to those Members of Congress who recently introduced legislation to protect the Food and Drug Administration’s (FDA) user fees from sequestration.

In 2012, Congress passed the FDA Safety and Innovation Act (FDASIA). As a result, new fees – paid by drug and device manufacturers – were instituted to provide the FDA with a much needed funding stream to provide for improvements to their drug and device review processes. This dedicated funding stream was designed to facilitate timely patient access to safe and effective new and generic medicines, medical devices and diagnostics.